Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

HealthLynked (HLYK) Cost of Revenue (2019 - 2025)

HealthLynked (HLYK) has disclosed Cost of Revenue for 7 consecutive years, with $207068.0 as the latest value for Q3 2025.

  • On a quarterly basis, Cost of Revenue fell 40.75% to $207068.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $1.1 million, a 32.14% decrease, with the full-year FY2024 number at $1.6 million, down 29.4% from a year prior.
  • Cost of Revenue was $207068.0 for Q3 2025 at HealthLynked, down from $247395.0 in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $1.7 million in Q3 2021 to a low of $207068.0 in Q3 2025.
  • A 5-year average of $532946.1 and a median of $511004.0 in 2021 define the central range for Cost of Revenue.
  • Peak YoY movement for Cost of Revenue: soared 695.51% in 2021, then tumbled 60.24% in 2022.
  • HealthLynked's Cost of Revenue stood at $558405.0 in 2021, then grew by 19.83% to $669121.0 in 2022, then tumbled by 39.39% to $405555.0 in 2023, then dropped by 17.28% to $335487.0 in 2024, then tumbled by 38.28% to $207068.0 in 2025.
  • Per Business Quant, the three most recent readings for HLYK's Cost of Revenue are $207068.0 (Q3 2025), $247395.0 (Q2 2025), and $313976.0 (Q1 2025).